Latest News- Women Health Therapeutics Market: Fertility is expected to lead the Type segment during 2024-2028
The Women Health Therapeutics Market is being driven by Growing attention toward women health
The Women Health Therapeutics Market is expected to grow at a CAGR of 6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 37.2 billion. Multiple organizations, including the Centers for Disease Control and Prevention (CDC), are actively working to increase public awareness about various gynecological disorders, such as gynecological cancers, maternity disorders, and infectious diseases. The CDC's Inside Knowledge campaign offers valuable information to the public regarding gynecological cancers. Additionally, annual events like Ovarian Cancer Awareness Month and Uterine Cancer Awareness Month, held in September, aim to raise awareness and education about these diseases. The Foundation for Women's Cancer in the US also observes September as Gynecologic Cancer Awareness Month each year. Furthermore, various organizations focus on increasing patient awareness about the major sub-types of gynecological disorders.
Get more information on Women Health Therapeutics Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Type (Fertility, Oncology, Menopause, Infection, Others) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Women Health Therapeutics Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Women's Health Therapeutics Market encompasses various health conditions including Menopause, Polycystic Ovary Syndrome, Breast cancer, and Hormonal imbalances. It also covers advanced contraceptive methods, Targeted therapies, Endometriosis, Infertility, Sexually Transmitted Infections, and Hormonal disorders. Additionally, it addresses reproductive health concerns such as Osteoporosis, Chronic diseases, and Pregnancy complications. Health education, E-commerce, Digital healthcare, and Assisted reproductive technologies are also part of this market. Lifestyle-related diseases, Oncology, and Precision medicine are key areas of focus. Therapeutic drugs are used to treat conditions like Cancer, Infections, and Hormonal disorders. Non-hormonal options, Vaginal capsule OUI, and Observational research are other significant aspects of this market.
The Women's Health Therapeutics market segment within the global pharmaceuticals industry encompasses companies and researchers involved in the development and production of non-generic and generic drugs, as well as veterinary medicines. According to Technavio's market analysis, key growth drivers for the pharmaceuticals sector include an aging population, with the global population over 60 years projected to reach nearly one-quarter by 2050 in the US and Europe by 2030. Other factors fueling market expansion include the rising prevalence of conditions such as menopause, polycystic ovary syndrome, breast cancer, endometriosis, infertility, sexually transmitted infections, and the increasing adoption of advanced contraceptive methods and targeted therapies, as well as the emergence of personalized medicine.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted